The number of bioequivalence study protocol approved in the first half year (January-June) was a total of 85 cases

Published: 2014-07-02 16:24:40

Updated: 2014-07-02 16:24:40

On June 30, according to the Ministry of Food and Drug Safety, the number of bioequivalence study protocol approved in the first half year (January-June) was a total of 85 cases.

Celebrex (Pfizer Korea, celecoxib) recorded the highest number of approved bioequivalence study protocol of 10 cases. Daewoong Pharmaceutical, Donga ST, Yuhan Corporation, Whanin Pharmaceutical, BC World Pharmaceutica...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.